Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease
Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes · 2026
Read Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease by Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13398127.txt.
Description
Clare Wotton and colleagues probe links between blood vessel disease, common painkillers and Parkinson's disease in the Million Women Study. Their 2026 analysis follows 819,575 women from around 2001 for a first hospital stay or death tied to Parkinson's. Past vessel disease had been linked to higher Parkinson's risk, but illness running the other way could fake the pattern.
Heart and brain vessel histories came from hospital records and self-report, as did use of aspirin and ibuprofen. Over an average 18 years of follow-up, 10,364 women developed Parkinson's disease in the records. Adjusted models then weighed whether vessel history truly raises risk and whether the painkillers lower it once that history is accounted for.
Catalog record
| CREATOR | Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25723 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |